Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group

O. Schnell, E. Standl, D. Catrinoiu, B. Itzhak, N. Lalic, D. Rahelic, J. Skrha, P. Valensi, A. Ceriello,

. 2019 ; 18 (1) : 30. [pub] 20190311

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kongresy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027726

The 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group was held in Munich on 25-26 October 2018. As in previous years, this summit served as a reference meeting for in-depth discussions on the topic of recently completed and presented CVOTs. This year, focus was placed on the CVOTs CARMELINA, DECLARE-TIMI 58 and Harmony Outcomes. Trial implications for diabetes management and the impact of the new ADA/EASD consensus statement treatment algorithm were highlighted for diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners. Discussions evolved from CVOTs to additional therapy options for heart failure (ARNI), knowledge gained for adjunct therapy of type 1 diabetes and, on the occasion of the 10 year anniversary of the FDA's "Guidance for Industry: "should CVOTs be continued and/or modified?" The 5th Cardiovascular Outcome Trial Summit will be held in Munich on 24-25 October 2019 ( http://www.cvot.org ).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027726
003      
CZ-PrNML
005      
20190822094441.0
007      
ta
008      
190813s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12933-019-0822-4 $2 doi
035    __
$a (PubMed)30857522
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Schnell, Oliver $u Forschergruppe Diabetes e. V., Ingolstaedter Landstraße 1, Neuherberg, 85764, Munich, Germany. oliver.schnell@lrz.uni-muenchen.de.
245    10
$a Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group / $c O. Schnell, E. Standl, D. Catrinoiu, B. Itzhak, N. Lalic, D. Rahelic, J. Skrha, P. Valensi, A. Ceriello,
520    9_
$a The 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group was held in Munich on 25-26 October 2018. As in previous years, this summit served as a reference meeting for in-depth discussions on the topic of recently completed and presented CVOTs. This year, focus was placed on the CVOTs CARMELINA, DECLARE-TIMI 58 and Harmony Outcomes. Trial implications for diabetes management and the impact of the new ADA/EASD consensus statement treatment algorithm were highlighted for diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners. Discussions evolved from CVOTs to additional therapy options for heart failure (ARNI), knowledge gained for adjunct therapy of type 1 diabetes and, on the occasion of the 10 year anniversary of the FDA's "Guidance for Industry: "should CVOTs be continued and/or modified?" The 5th Cardiovascular Outcome Trial Summit will be held in Munich on 24-25 October 2019 ( http://www.cvot.org ).
650    _2
$a biomedicínský výzkum $x metody $x normy $7 D035843
650    _2
$a kardiologie $x metody $x normy $7 D002309
650    _2
$a kardiovaskulární nemoci $x diagnóza $x epidemiologie $x terapie $7 D002318
650    _2
$a klinické zkoušky jako téma $x metody $x normy $7 D002986
650    _2
$a kooperační chování $7 D003299
650    _2
$a diabetes mellitus $x diagnóza $x farmakoterapie $x epidemiologie $7 D003920
650    _2
$a endokrinologie $x metody $x normy $7 D004704
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x škodlivé účinky $x terapeutické užití $7 D007004
650    _2
$a mezioborová komunikace $7 D033183
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kongresy $7 D016423
700    1_
$a Standl, Eberhard $u Forschergruppe Diabetes e. V., Ingolstaedter Landstraße 1, Neuherberg, 85764, Munich, Germany.
700    1_
$a Catrinoiu, Doina $u Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd. No. 145, 900591, Constanța, Romania.
700    1_
$a Itzhak, Baruch $u Clalit Health Services and Technion Faculty of Medicine, 3 Zivoni Street, Haifa, Israel.
700    1_
$a Lalic, Nebojsa $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
700    1_
$a Rahelic, Dario $u Diabetes and Metabolic Disorders, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000, Zagreb, Croatia.
700    1_
$a Skrha, Jan $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U Nemocnice 1, 128 08, Prague 2, Czech Republic.
700    1_
$a Valensi, Paul $u Department of Endocrinology Diabetology Nutrition, CINFO, CRNH-IdF, Jean VERDIER Hospital, Paris 13 University, Avenue du 14 Juillet, 93140, Bondy, France.
700    1_
$a Ceriello, Antonio $u Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain. Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
773    0_
$w MED00008211 $t Cardiovascular diabetology $x 1475-2840 $g Roč. 18, č. 1 (2019), s. 30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30857522 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822094720 $b ABA008
999    __
$a ok $b bmc $g 1432875 $s 1066186
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 18 $c 1 $d 30 $e 20190311 $i 1475-2840 $m Cardiovascular diabetology $n Cardiovasc Diabetol $x MED00008211
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace